CORRECTION — MannKind Corporation Reports 2023 First Quarter Financial Results
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 09, 2023 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by MannKind Corporation (Nasdaq:MKND), please note in the second table, titled “CONDENSED CONSOLIDATED BALANCE SHEETS”, the right column header was incorrectly labeled as “March 31, 2022”, when it should be labeled “December 31, 2022”. The corrected release follows:
Related news for (MNKD)
- Cybersecurity Surges, Biotech Booms & SaaS Shifts- 7 Hot Stocks Lighting Up into the Close
- 24/7 Market News Snapshot 27 August, 2025 – Mannkind Corporation (NASDAQ:MNKD)
- MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
- MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
- MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23